Oscar Health Edges Past Estimates, Targets Profitability by 2026

Oscar Health (OSCR) shares gained in premarket trading after the health insurer beat analyst EPS expectations by one cent and outlined its plan to return to profitability in 2026.

Q3 Results

Adjusted EPS: -$0.53 vs. -$0.54 expected (FactSet)
Revenue: $2.92B vs. $3.07B expected
Medical Loss Ratio: 88.5% vs. 88.8% expected

CEO Mark Bertolini said:

“We are confident in our ability to expand margins and return to profitability in 2026.”

Sector Context

Health insurers, especially those offering government-sponsored plans, have been navigating rising medical costs and claims pressure this year. Oscar’s slightly better-than-expected MLR suggests some cost control progress despite revenue softness.

Market Reaction

Shares were up modestly in premarket trading, with analysts noting the company’s improving operating discipline and long-term margin visibility.